Acceleron Pharma Q3 EPS $(0.86) Misses $(0.82) Estimate, Sales $4.21M Miss $4.44M Estimate

Acceleron Pharma (NASDAQ:XLRN) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $(0.82) by 4.88 percent. This is a 36.51 percent decrease over losses of $(0.63) per share from

Benzinga · 11/06/2019 12:54

Acceleron Pharma (NASDAQ:XLRN) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $(0.82) by 4.88 percent. This is a 36.51 percent decrease over losses of $(0.63) per share from the same period last year. The company reported quarterly sales of $4.21 million which missed the analyst consensus estimate of $4.44 million by 5.18 percent. This is a 29.22 percent increase over sales of $3.258 million the same period last year.